Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients (Q43135416)

From Wikidata

Jump to navigation Jump to search

scientific article published in March 2010

Language	Label	Description	Also known as
English	Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients	scientific article published in March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Different patterns of longitudinal changes in plasma levels of catecholamine metabolites and brain-derived neurotrophic factor after administration of atypical antipsychotics in first episode untreated schizophrenic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

0 references

Wakako Umene-Nakano

5

object named as

Wakako Umene-Nakano

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Reiji Yoshimura

1

object named as

Reiji Yoshimura

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

6

object named as

Jun Nakamura

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Atsuko Ikenouchi-Sugita

4

object named as

Atsuko Ikenouchi-Sugita

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

2

object named as

Nobuhisa Ueda

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

3

object named as

Hikaru Hori

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

1 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

World Journal of Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

2 Pt 2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

256-261

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Anterograde transport of brain-derived neurotrophic factor and its role in the brain

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Brain derived neurotropic factor in first-episode psychosis

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

High-quality remission: potential benefits of the melatonergic approach for patients with major depressive disorder

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Antipsychotic drugs influence transport of the beta-adrenergic antagonist [3H]-dihydroalprenolol into neuronal and blood cells

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

The impact of age, weight and gender on BDNF levels in human platelets and plasma

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

3-Methoxy-4-Hydroxyphenethyleneglycol Production by Human Brain in Vivo

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF.

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics.

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Neurotrophins and neuronal plasticity

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Proposal for a noradrenaline hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Inhibitory effects of clozapine and other antipsychotic drugs on noradrenaline transporter in cultured bovine adrenal medullary cells

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Plasma levels of homovanillic acid and the response to risperidone in first episode untreated acute schizophrenia

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Clinical response to antidepressant treatment and 3-methoxy-4-hydroxyphenylglycol levels: mini review

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Effects of zotepine and olanzapine on noradrenaline transporter in cultured bovine adrenal medullary cells

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Treatment with risperidone for 4 weeks increased plasma 3-methoxy-4-hydroxypnenylglycol (MHPG) levels, but did not alter plasma brain-derived neurotrophic factor (BDNF) levels in schizophrenic patients

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

1 reference

https://api.crossref.org/works/10.3109%2F15622970802309617

21 January 2018

Identifiers

10.3109/15622970802309617

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43135416&oldid=1981409766"